Document Detail

Methylcobalamin effects on diabetic neuropathy and nerve protein kinase C in rats.
MedLine Citation:
PMID:  21128935     Owner:  NLM     Status:  In-Data-Review    
Eur J Clin Invest 2011; 41 (4): 442-450 ABSTRACT: Background  Methyl-base-attached cobalamin (Methycobalamin) (MC) has a special affinity for nerve tissues to promote myelination and transport of axonal cytoskeleton. It is not known, however, how MC influences on peripheral nerve in experimental diabetic neuropathy. Materials and methods  We studied the effects of MC on expressions and activities of protein kinase C (PKC) in peripheral nerve of streptozotocin-induced diabetic rats. Wistar rats, 8 weeks of age, were rendered diabetic by streptozotocin (40 mg kg(-1) , iv) and followed for 16 weeks. A half of diabetic animals were treated with MC (10 mg kg(-1) per every other day, im) after the induction of diabetes. Normal Wistar rats were served as control. Results  At the end, untreated diabetic animals developed significant delay of nerve conduction velocity (NCV), and MC treatment normalized the NCV. Nerve PKC activity was significantly suppressed in untreated diabetic rats, while the activity was normalized in treated animals. While PKCα located in Schwann cells, PKCβΙα and βII distributed in axoplasm, vascular walls and macrophages. The decreased PKC activity in diabetic nerve was associated with reduced expression of membrane PKCα and increased membrane expression of PKCβII, and MC treatment corrected these changes. Diabetic nerve contained an increased number of macrophages and 8-hydroxydeoxyguanosine-positive cells in the endoneurium, the latter of which was significantly suppressed by MC treatment. Elevated nerve polyol levels in diabetic nerve were partially corrected by MC treatment. Conclusions  This study suggested that correction of impaired neural signalling of PKC and oxidative stress-induced damage may be a major attribute to the beneficial effects of MC on diabetic nerve.
Hiroki Mizukami; Saori Ogasawara; Shin-Ichiro Yamagishi; Kazunori Takahashi; Soroku Yagihashi
Related Documents :
22526605 - Genetic association of zinc transporter 8 (znt8) autoantibodies in type 1 diabetes cases.
2019925 - Pancreatic endocrine function in cystic fibrosis.
22919445 - Hla-dqb1* alleles and genetic susceptibility to type 1 diabetes mellitus.
7018145 - The effects of cyproheptadine on glucose tolerance and pancreatic islets in rats.
18358255 - Obesity surgery: evidence for diabetes prevention/management.
18199105 - Reduction of proteinuria by rosiglitazone in non-diabetic renal disease.
Publication Detail:
Type:  Journal Article     Date:  2010-12-03
Journal Detail:
Title:  European journal of clinical investigation     Volume:  41     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  442-50     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.
Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High risk of cardiovascular disease in iron overload patients.
Next Document:  Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol...